Warm congratulations to parent company Bubu Bus (BeBeBus) on its Hong Kong IPO — Gaorong Ventures is the largest institutional investor.
"The first publicly listed maternal and infant consumer tech company."
高榕创投
@gaorong
创造美好生活
531 articles
Articles
Millions of Dollars per Unit: How Shuimu Biosciences Plans to Slash Cryo-EM Costs with "AI plus Domestic Manufacturing" | Gaorong Future
Scaling the Summit of Domestic Cryo-EM Manufacturing.
Nothing Closes $200 Million Series C, CEO Carl Pei: First AI-Native Devices Coming Next Year
Reshaping the way technology unlocks human potential.
3D Cell Manufacturing Platform Huaxin Biotech Closes Series B+ Round to Accelerate Cell Therapy Commercialization for Global Clients
Ushering in the 2.0 era of cell-based industrialization.
Creating Eyes for the AI World, Adaps Photonics Closes C3 Round to Accelerate Robotics Push
Secured large-scale deployment with top-tier clients.
Rongbao | Multiple autonomous driving, nuclear fusion, gaming, and innovative drug companies raise hundreds of millions of RMB in funding
From commercial deployment to world-first breakthroughs, innovation never stands still.
From Metabolic Drugs to the Weight-Loss Track: How an Innovative Pharma Company Built Momentum | Gaorong Future
Adhere to the "first principles" of new drug R&D.
XVERSE: AI + 3D, Unlocking a More Realistic, More Intelligent Digital New World | Gaorong Future
Always standing at the cutting edge of 3D and AI technology.
Nuro Closes Over $200 Million Series E to Scale AI-First Autonomous Driving Technology
Make self-driving technology accessible to everyone.
Haichang Biotech Closes Nearly 500 Million Yuan Series C Round to Accelerate Development of Innovative Nucleic Acid Drugs and Complex Injectables
Focused on the R&D and industrial application of drug delivery system technologies.